Stemline Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for STEMLINE THERAP, and when can generic versions of STEMLINE THERAP drugs launch?
STEMLINE THERAP has one approved drug.
There are eight US patents protecting STEMLINE THERAP drugs.
There are one hundred and two patent family members on STEMLINE THERAP drugs in twenty-five countries and six supplementary protection certificates in six countries.
Summary for Stemline Therap
| International Patents: | 102 |
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Stemline Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-002 | Jan 27, 2023 | RX | Yes | Yes | 10,071,066 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-002 | Jan 27, 2023 | RX | Yes | Yes | 8,399,520 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-001 | Jan 27, 2023 | RX | Yes | No | 10,745,343 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-002 | Jan 27, 2023 | RX | Yes | Yes | 10,420,734 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Stemline Therap | ORSERDU | elacestrant dihydrochloride | TABLET;ORAL | 217639-001 | Jan 27, 2023 | RX | Yes | No | 8,399,520 | ⤷ Sign Up | Y | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Stemline Therap Drugs
Supplementary Protection Certificates for Stemline Therap Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3122426 | LUC00331 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: ELACESTRANT OU UN SEL DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/23/1757 20230918 |
| 3122426 | 122024000013 | Germany | ⤷ Sign Up | PRODUCT NAME: ELACESTRANT ODER EIN SALZ DAVON; REGISTRATION NO/DATE: EU/1/23/1757 20230915 |
| 3122426 | CA 2024 00007 | Denmark | ⤷ Sign Up | PRODUCT NAME: ELACESTRANT OR A SALT THEREOF; REG. NO/DATE: EU/1/23/1757 20230918 |
| 3122426 | 301263 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ELACESTRANT OF EEN ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/23/1757 20230918 |
| 3122426 | PA2024504 | Lithuania | ⤷ Sign Up | PRODUCT NAME: ELACESTRANTAS ARBA JO DRUSKA; REGISTRATION NO/DATE: EU/1/23/1757 20230915 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
